The global landscape of veterinary healthcare is poised for a transformative journey as the Global Veterinary Auto-Immune Therapeutics Industry is projected to reach a remarkable valuation of US$ 71,720.6 million by 2033. This projection marks a substantial increase from the US$ 42,815.7 million recorded in 2023, showcasing an impressive compound annual growth rate (CAGR) of …
Category Archives: Healthcare Trends
Global Angiographic Catheters Industry Anticipates a 4.3% CAGR Leading to a US$2.2 Billion Valuation By 2033 | FMI
The Global Angiographic Catheters Industry is gearing up for a period of substantial growth, with a projected valuation of US$ 2,215.4 million by the year 2033. This promising ascent represents a significant increase from its 2023 figure of US$ 1,451.0 million, reflecting an impressive Compound Annual Growth Rate (CAGR) of 4.3% Angiographic catheters play a …
Global Retractable Needle Safety Syringes Industry Heads Towards US$ 8,770 Million by 2033, Fueled by a 4.1% CAGR | FMI
The Global Industry for Retractable Needle Safety Syringes is poised for significant growth, with a projected valuation of US$ 5,846.6 million in 2023. The market is anticipated to maintain a steady Compound Annual Growth Rate (CAGR) of 4.1% from 2023 to 2033, ultimately reaching around US$ 8,770 million by 2033. This promising trajectory underscores the …
Biomedical Refrigerators and Freezers Market Preserves Medical Precision with a Forecasted 5.9% CAGR from 2022 to 2032-FMI Study
The biomedical refrigerators and freezers market production, marketing, and distribution of specialised ntended to store and preserve a variety of biomedical materials, including vaccines, drugs, blood products, tissue samples, and laboratory reagents, are the main activities of the biomedical refrigerators and freezers market, a subsector of the medical equipment industry. The survival and integrity of …
Luciferase Assays Market Poised to Surpass US$ 3 Billion by 2032-FMI Study
The luciferase assays market is divided geographically into seven regions: Asia-Pacific (excluding Japan), Eastern Europe, Western Europe, North America, Latin America, Middle East & Africa, and Eastern Europe. North America is expected to remain the dominating region, but Asia Pacific is expected to grow at the fastest rate. Because of government financing for research and …
Continue reading “Luciferase Assays Market Poised to Surpass US$ 3 Billion by 2032-FMI Study”
Global Sialendoscopes Market forecasts a US$ 307.9 Million value by 2032, resonating with the rise in salivary gland disorder occurrences | FMI
The sialendoscopes market is expected to grow from US$ 169.2 million in 2022 to US$ 307.9 million by 2032, at a CAGR of 5.6%. The growth of the market is attributed to the increasing prevalence of salivary gland diseases, such as sialolithiasis, salivary duct strictures, and salivary gland tumors. Sialendoscopes are minimally invasive devices used …
Hernia Mesh Devices Market Embarks on the Road to US$ 6.5 Billion by 2032-FMI Study
Future Market Insights (FMI) anticipated that the global hernia mesh devices market will be valued US$ 4.5 billion in 2021 and is expected to reach US$ 6.5 billion by 2032. According to the report’s findings, inguinal hernias will still account for 80% of all hernias. They are the most prevalent type of hernia, occurring in …
Global Quantitative Pathology Imaging Market, as projected by FMI, is set for an 11.9% CAGR by 2032 | FMI
The global quantitative pathology imaging market is expected to reach US$ 9.5 billion by 2032, up from US$ 2.77 billion in 2022, advancing at a CAGR of 11.9% during the forecast period. Quantitative pathology imaging (QPI) is a rapidly growing field that uses advanced imaging and computational technologies to analyze tissue samples for quantitative information. …
Stem Cell Therapy Market Resilience Illuminated with a Projected 16.7% CAGR Growth from 2022 to 2032-FMI Study
At a compound annual growth rate (CAGR) of 16.7%, the stem cell therapies market is expected to grow from US$ 187 million in 2021 to US$ 401 million by 2026 at a CAGR of 16.7%, by 2032. The COVID-19 pandemic has caused severe impacts on the global economy at various levels and which can be …
Global Reverse Transcriptase Enzymes Market might potentially achieve US$ 481.8 Million by 2032, driven by a 3.4% CAGR, according to estimates | FMI
The global reverse transcriptase enzymes market is expected to reach US$ 335.0 Million in 2022. By 2032, the market for reverse transcriptase enzymes is anticipated to reach US$ 481.8 Million with a CAGR of 3.4%. Reverse Transcriptase Enzymes market share analysis, winning strategies, latest advancements, and financial plans are just a few of the critical …